Vir Biotechnology, Inc. (VIR): Hedge Funds Aren't Enthusiastic
Before we spend countless hours researching a company, we like to analyze what insiders, hedge funds and billionaire investors think of the stock first.
Vir Biotechnology Inc. (VIR)
Market is closed
News
- First
- << Previous
- 21 - 23
Trumpdesivir: Operation Warp Speed, “Engage.”
The COVID-19 vaccine race officially goes into high gear with the announcement of USA’s plan to test the 6-odd top vaccine candidates across upwards of 150,000 volunteers (min.
Stocks Amid COVID-19 Outbreak: Winners So Far in the Health Industry
At its worst on March 23rd, Dow Jones and the S&P declined by around 37% and 34%. At the time, those kinds of numbers represented a loss of a 3-year gain since Trump’s election in November of 2016.
- First
- << Previous
- 21 - 23
Billionaire Hedge Funds
